Profile picture

Professor Stefano Perlini

University of Pavia, Pavia (Italy)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Estimated glomerular filtration rate trajectories by transthyretin stabilisation status in ATTR-ACT
Presentation
Estimated glomerular filtration rate trajectories by transthyretin stabilisation status in ATTR-ACT
See more
Comparative efficacy and safety of tafamidis versus acoramidis in transthyretin amyloid cardiomyopathy: a matching-adjusted indirect comparison
Presentation
Comparative efficacy and safety of tafamidis versus acoramidis in transthyretin amyloid cardiomyopathy: a matching-adjusted indirect comparison
See more
Q&A
Presentation
Q&A
See more
Panel discussion
Presentation
Panel discussion
See more
From evidence to outcomes: leveraging long-term data in ATTR-CM
Presentation
From evidence to outcomes: leveraging long-term data in ATTR-CM
See more
Transthyretin (TTR) stabilisation in ATTR cardiomyopathy: myths, measures, and meaning
Presentation
Transthyretin (TTR) stabilisation in ATTR cardiomyopathy: myths, measures, and meaning
See more
Transthyretin (TTR) stabilisation in ATTR cardiomyopathy: myths, measures, and meaning
Presentation
Transthyretin (TTR) stabilisation in ATTR cardiomyopathy: myths, measures, and meaning
See more
How can trial and real-world ATTR cardiomyopathy data support clinical practice?
Presentation
How can trial and real-world ATTR cardiomyopathy data support clinical practice?
See more
Management of ATTR-CM: from clinical trial data to real-world evidence
Presentation
Management of ATTR-CM: from clinical trial data to real-world evidence
See more
The correct diagnosis in this case, and why
Presentation
The correct diagnosis in this case, and why
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources